×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Heart Disease | High Cholesterol | esperion | cholesterol | drug | trial

New Cholesterol Drug Shows Promise

Tuesday, 17 March 2015 08:24 AM

Esperion Therapeutics said its experimental drug showed greater reductions in cholesterol levels when compared with a placebo in a mid-stage study.

Patients taking doses of 120 mg and 180 mg of the drug, ETC-1002, showed 17 and 24 percent greater reduction in bad cholesterol levels.

The study was evaluating safety and effectiveness of the drug in patients with high cholesterol levels.

© 2021 Thomson/Reuters. All rights reserved.


Health-News
Esperion Therapeutics said its experimental drug showed greater reductions in cholesterol levels when compared with a placebo in a mid-stage study. Patients taking doses of 120 mg and 180 mg of the drug, ETC-1002, showed 17 and 24 percent greater reduction in bad cholesterol...
esperion, cholesterol, drug, trial
61
2015-24-17
Tuesday, 17 March 2015 08:24 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved